Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
ZimVie Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 8-K Quarterly results
05/18/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "ZIMVIE INC. 2022 STOCK INCENTIVE PLAN 1. General: Establishment of Plan. The ZimVie Inc. 2022 Stock Incentive Plan was originally established effective as of March 1, 2022 . The Plan, as amended, will become effective on May 12, 2023 upon the affirmative vote of a majority of votes cast at the 2023 annual meeting of stockholders. Purpose. The purpose of the Plan is to promote the success and enhance the value of the Company by linking the personal interests of service providers of the Company to those of the Company's stockholders and by providing persons who provide services to the Company with long-term incentives for outstanding performance. The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract and retain the services of such persons who ..."
05/03/2023 8-K Quarterly results
03/01/2023 8-K Quarterly results
Docs: "ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results",
"Presentation"
02/22/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Amended and Restated Bylaws of ZimVie Inc., effective as of February 17, 2023",
"Amended and Restated Bylaws of ZimVie Inc., effective as of February 17, 2023"
11/09/2022 8-K Quarterly results
Docs: "ZimVie Reports Third Quarter 2022 Financial Results • Third party net sales of $213.3 million • Net income of $0.8 million; net income margin of 0.4%; adjusted net income[1] of $12.9 million • Diluted EPS of $0.03; adjusted diluted EPS[1] of $0.49 • Adjusted EBITDA[1] of $29.4 million; adjusted EBITDA margin[1] of 13.8% • Cash and cash equivalents of $116.0 million at September 30, 2022 • Reaffirming full-year 2022 guidance for third party net sales, adjusted EBITDA margin[2], and adjusted EPS[2]"
08/12/2022 8-K Regulation FD Disclosure  Interactive Data
08/10/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
Docs: "ZimVie Reports First Quarter 2022 Financial Results • Third party net sales of $234.7 million, inclusive of $120.6 million in dental net sales and $114.1 million in spine net sales • Net loss of million; net loss as a percentage of net sales of ; adjusted net income[1] of $13.1 million • Diluted EPS of ; adjusted diluted EPS of $0.50[1] • Adjusted EBITDA[1] of $33.8 million; adjusted EBITDA margin[1] of 14.4% • Cash balance of $104.3 million at March 31, 2022"
03/31/2022 8-K Quarterly results
Docs: "ZimVie Reports 2021 Financial Results, Reaffirms 2022 Financial Guidance, and Provides Supplemental Financial Information • 2021 third party revenue of $1.009 billion, inclusive of $469 million in dental revenue and $540 million in spine revenue • Completed spine brand rationalization in the second half of 2021, resulting in a charge of $40 million • Successfully spun-off into an independent, publicly traded company effective March 1, 2022 • Reaffirming 2022 financial guidance"
03/07/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
02/22/2022 8-K Quarterly results
02/07/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : February 7, 2022 ZIMVIE INC. Delaware 001-41242 87-2007795 10225 Westmoor Drive Westminster, Colorado 80021 Registrant's telephone number, including area code: 443-7500 Not applicable",
"ZimVie Inc. Investor Presentation",
"ZimVie Hosts Inaugural Investor Day; Provides 2022 Financial Outlook February 7, 2022—ZimVie, the intended standalone, publicly traded entity to be spun off from Zimmer Biomet Holdings, Inc. , will host its inaugural Investor Day today, February 7, 2022, from 11:00 a.m. to approximately 2:00 p.m. Eastern Time. Investors can access the webcast here or by visiting Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com . The virtual event will feature presentations from ZimVie leaders outlining its Spine and Dental offerings, addressable market opportunity, business strategy, and financial outlook. The event will feature a live Q&A panel following speaker presentations. 1 In conjunction with the event, ZimVie is providing the following full-year 2022 financial guidanc..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy